Efficacy of oral transmucosal and intravenous administration of buprenorphine before surgery for postoperative analgesia in dogs undergoing ovariohysterectomy

Journal of the American Veterinary Medical Association

Volumn 238, Issue 3, 2011, Pages 318-328

  Ko, Jeff C ^a   Freeman, Lynetta J ^a   Barletta, Michele ^a   Weil, Ann B ^a,c   Payton, Mark E ^b   Johnson, Brenda M ^a   Inoue, Tomohito ^a  

^a PURDUE UNIVERSITY   (United States)

^b 301 MSCS   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; BUPRENORPHINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOG; DOG DISEASE; FEMALE; HYSTERECTOMY; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; OVARIECTOMY; POSTOPERATIVE PAIN; RANDOMIZED CONTROLLED TRIAL; TIME;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; BUPRENORPHINE; DOG DISEASES; DOGS; FEMALE; HYSTERECTOMY; INJECTIONS, INTRAVENOUS; OVARIECTOMY; PAIN, POSTOPERATIVE; TIME FACTORS;

ANIMALIA; CANIS FAMILIARIS;

EID: 79951824316     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: 10.2460/javma.238.3.318     Document Type: Article

References (35)

1. Shih AC, Robertson S, Isaza N, et al. Comparison between analgesic effects of buprenorphine, carprofen, and buprenorphine with carprofen for canine ovariohysterectomy. Vet Anaesth Analg 2008;35:69-79.
2. Gurney M, Cripps P, Mosing M. Subcutaneous pre-anaesthetic medication with acepromazine-buprenorphine is effective as and less painful than the intramuscular route. J Small Anim Pract 2009;50:474-477.
3. Slingsby LS, Taylor PM, Waterman-Pearson AE. Effects of two doses of buprenorphine four or six hours apart on nociceptive thresholds, pain and sedation in dogs after castration. Vet Rec 2006;159:705-711. (Pubitemid 46017295)
4. Bennett RC, Fancy SP, Walsh CM, et al. Comparison of sevoflurane and isoflurane in dogs anaesthetised for clinical surgical or diagnostic procedures. J Small Anim Pract 2008;49:392-397.
5. Uilenreef JJ, Murrell JC, McKusick BC, et al. Dexmedetomidine continuous rate infusion during isoflurane anaesthesia in canine surgical patients. Vet Anaesth Analg 2008;35:1-12.
6. Bosmans T, Gasthuys F, Duchateau L, et al. A comparison of tepoxalin-buprenorphine combination and buprenorphine for postoperative analgesia in dogs: a clinical study. J Vet Med A Physiol Pathol Clin Med 2007;54:364-369. (Pubitemid 47300724)
7. Leppãnen MK, McKusick BC, Granholm MM, et al. Clinical efficacy and safety of dexmedetomidine and buprenorphine, butorphanol or diazepam for canine hip radiography. J Small Anim Pract 2006;47:663-669. (Pubitemid 44656941)
8. Dohoo SE, Tasker RA. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations. Can J Vet Res 1997;61:251-255. (Pubitemid 27497662)
9. KuKanich B. Lascelles BD, Papich MG. Pharmacokinetics of morphine and plasma concentrations of morphine-6-glucuronide following morphine administration to dogs. J Vet Pharmacol Ther 2005;28:371-376. (Pubitemid 41098178)
10. Garrett ER, Chandran VR. Pharmacokinetics of morphine and its surrogates. X: analyses and pharmacokinetics of buprenorphine in dogs. Biopharm Drug Dispos 1990;11:311-350. (Pubitemid 20210752)
11. McInnes F, Clear N, James G, et al. Evaluation of the clearance of a sublingual buprenorphine spray in the beagle dog using gamma scintigraphy. Pharm Res 2008;25:869-874. (Pubitemid 351661835)
12. Bullingham RE, McQuay HJ, Porter EJ, et al. Sublingual buprenorphine used postoperatively: ten hour plasma drug concentration analysis. Br J Clin Pharmacol 1982;13:665-673. (Pubitemid 13139882)
13. Kuhlman JJ Jr, Lalani S, Magluilo J Jr, et al. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. J Anal Toxicol 1996;20:369-378. (Pubitemid 26327458)
14. Weinberg DS, Inturrisi CE, Reidenberg B, et al. Sublingual absorption of selected opioid analgesics. Clin Pharmacol Ther 1988;44:335-342.
15. Nath RP, Upton RA, Everhart ET, et al. Buprenorphine pharmacokinetics: relative bioavailability of sublingual tablet and liquid formulations. J Clin Pharmacol 1999;39:619-623. (Pubitemid 30629042)
16. Streisand JB, Zhang J, Niu S, et al. Buccal absorption of fentanyl is pH-dependent in dogs. Anesthesiology 1995;82:759-764.
17. Goswami T, Jasti B, Li X. Sublingual drug delivery. Crit Rev Ther Drug Carrier Syst 2008;25:449-484.
18. Robertson SA, Lascelles BD, Taylor PM, et al. PK-PD modeling of buprenorphine in cats: intravenous and oral transmucosal administration. J Vet Pharmacol Ther 2005;28:453-460. (Pubitemid 41530772)
19. Krotscheck U, Boothe DM, Little AA. Pharmacokinetics of buprenorphine following intravenous administration in dogs. Am J Vet Res 2008;69:722-727. (Pubitemid 351891267)
20. Andaluz A, Moll X, Abellan R, et al. Pharmacokinetics of buprenorphine after intravenous administration of clinical doses to dogs. Vet J 2009;181:299-304.
21. Abbo LA, Ko JC, Maxwell LK, et al. Pharmacokinetics of buprenorphine following intravenous and oral transmucosal administration in dogs. Vet Ther 2008;9:83-93.
22. Carroll CL, Howe LB, Peterson KD. Analgesic efficacy of preoperative administration of meloxicam or butorphanol in onychectomized cats. J Am Vet Med Assoc 2005;226:913-919. (Pubitemid 40365791)
23. Johnson BM, Ko JC, Hall PJ, et al. Analgesic effect of bupivacaine eluting porcine small intestinal submucosa (SIS) in ferrets undergoing acute abdominal hernia defect surgery [published online ahead of print May 22, 2010]. J Sur Res doi:10.1016/j. jss.2010.04.055.
24. Kress HG. Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine. Eur J Pain 2009;13:219-230.
25. Yassen A, Olofsen E, Dahan A, et al. Pharmacokinetic-pharmacodynamic modeling of the antinociceptive effect of buprenorphine and fentanyl in rats: role of receptor equilibration kinetics. J Pharmacol Exp Ther 2005;313:1136-1149. (Pubitemid 40727017)
26. Yassen A, Olofsen E, Romberg R, et al. Mechanism-based pharmacokinetic- pharmacodynamic modeling of the antinociceptive effect of buprenorphine in healthy volunteers. Anesthesiology 2006;104:1232-1242. (Pubitemid 43852957)
27. Huang P, Kehner GB, Cowan A, et al. Comparison of pharmacological activities of buprenorphine and norbuprenorphine: norbuprenorphine is a potent opioid agonist. J Pharmacol Exp Ther 2001;297:688-695. (Pubitemid 32378001)
28. Filitz J, Griessinger N, Sittl R, et al. Effects of intermittent hemodialysis on buprenorphine and norbuprenorphine plasma concentrations in chronic pain patients treated with transdermal buprenorphine. Eur J Pain 2006;10:743-748. (Pubitemid 44430173)
29. Elkader A, Sproule B. Buprenorphine: clinical pharmacokinetics in the treatment of opioid dependence. Clin Pharmacokinet 2005;44:661-680. (Pubitemid 40994078)
30. Ohtani M, Kotaki H, Sawada Y, et al. Comparative analysis of buprenorphine- and norbuprenorphine-induced analgesic effects based on pharmacokinetic-pharmacodynamic modeling. J Pharmacol Exp Ther 1995;272:505-510.
31. Feary DJ, Mama KR, Wagner AE, et al. Influence of general anesthesia on pharmacokinetics of intravenous lidocaine infusion in horses. Am J Vet Res 2005;66:574-580. (Pubitemid 40553202)
32. Streisand JB, Varvel JR, Stanski DR, et al. Absorption and bioavailability of oral transmucosal fentanyl citrate. Anesthesiology 1991;75:223-229.
33. Inagaki Y, Kuzukawa A. Effects of epidural and intravenous buprenorphine on halothane minimum alveolar anesthetic concentration and hemodynamic responses. Anesth Analg 1997;84:100-105. (Pubitemid 27020967)
34. Martinez EA, Hartsfield SM, Melendez LD, et al. Cardiovascular effects of buprenorphine in anesthetized dogs. Am J Vet Res 1997;58:1280-1284. (Pubitemid 27479321)
35. Cowan A, Doxey JC, Harry EJ. The animal pharmacology of buprenorphine, an oripavine analgesic agent. Br J Pharmacol 1977;60:547-554. (Pubitemid 8149540)